Effect of helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: A prospective, cohort 2-year follow-up study

Journal of Clinical Gastroenterology

Volumn 42, Issue 6, 2008, Pages 744-749

  Tzathas, Charalambos ^a   Triantafyllou, Konstantinos ^b   Mallas, Elias ^b   Triantafyllou, George ^a   Ladas, Spiros D ^b,c  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cirrhosis; Helicobacter pylori eradication; Maintenance therapy; Peptic ulcer recurrence

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE; UREASE; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ABDOMINAL DISTENSION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DIARRHEA; DRUG INDUCED HEADACHE; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIVER CIRRHOSIS; MAINTENANCE THERAPY; MALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; TASTE DISORDER; TERTIARY HEALTH CARE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER HEALING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOSCOPY; GREECE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; COHORT STUDIES; ENDOSCOPY; FOLLOW-UP STUDIES; GREECE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 54649084177     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3180381571     Document Type: Article

References (26)

1. Dore MP, Mura D, Deledda S, et al. Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy. Can J Gastroenterol. 2004;18:521-524.
2. Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc. 1995;42:424-427.
3. Siringo S, Bolondi L, Piscaglia F, et al. Peptic ulcer in patients with liver cirrhosis. A retrospective endoscopic and clinical study. Ital J Gastroenterol Hepatol. 1997;29:62-68.
4. Vergara M, Calvet X, Roque M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol. 2002;14:717-722.
5. Siringo S, Burroughs AK, Bolondi L, et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol. 1995;22:633-641.
6. Kitano S, Dolgor B. Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? J Gastroenterol. 2000;35:79-86.
7. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence. Gastroenterology. 1996;110:1244-1252.
8. Anonymous. Reliability of endoscopy in the assessment of varices features. The Italian Liver Cirrhosis Project. J Hepatology. 1987; 4:93-98.
9. Spina GP, Arcidiacono R, Bosch J, et al. Gastric endoscopic features in portal hypertension: Final report of a consensus conference. Milan, Italy, September 19, 1992. J Hepatology. 1994;21: 461-467.
10. Kirk AP, Dooley JS, Hunt RH. Peptic ulceration in patients with chronic liver disease. Dig Dis Sci. 1980;25:756-760.
11. Di Mario F, Gottardello L, Germana B, et al. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Ital J Gastroenterol. 1992;24:122-125.
12. Lo GH, Yu HC, Chan YC, et al. The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc. 2005;62:350-356.
13. Saad RJ, Chey WD. Peptic ulcer disease in patients with chronic liver disease: looking beyond bugs and drugs. Gastrointest Endosc. 2005;62:357-359.
14. Saad RJ, Chey WD. A clinician's guide to managing Helicobacter pylori infection. Cleve Clin J Med. 2005;72:109-124.
15. Tsai CJ. Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci. 1998;43:1219-1225.
16. Wilder-Smith CH, Ernst T, Gennoni M, et al. Tolerance to oral H2 receptor antagonists. Dig Dis Sci. 1990;8:976-983.
17. Merki HS, Wilder-Smith CH. Do continuous omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology. 1994;106:60-64.
18. Hirschowitz BI, Lanas A. Atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse. J Clin Gastroenterol. 2002;34:523-528.
19. Chen LS, Lin HC, Lee FY, et al. Prevalence of duodenal ulcer in cirrhotic patients and its relation to Helicobacter pylori and portal hypertension. Zhonghua Yi Xue Za Zhi (Taipei). 1995;56:226-231.
20. Wang CH, Ma LR, Lin RC, et al. Helicobacter pylori infection and risk of peptic ulcer among cirrhotic patients. J Formos Med Assoc. 1997;96:55-58.
21. Savarino V, Mela GS, Zentilin P, et al. Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. J Hepatol. 1996;25: 152-157.
22. Lo WC, Lin HJ, Wang K, et al. Gastric secretion in Chinese patients with cirrhosis. J Clin Gastroenterol. 1996;23:256-260.
23. Fugiwata Y, Arakawa T, Higuchi K, et al. Gastrointestinal lesions in liver cirrhosis. Nippon-Rincho. 1998;56:2387-2390.
24. Zullo A, Rinaldi V, Meddi P, et al. Helicobacter pylori infection in dyspeptic cirrhotic patients. Hepatogastroenterology. 1999;46: 395-400.
25. Kamalaporn P, Sobhonslidsuk A, Jatchavala J, et al. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther. 2005;21:1459-1465.
26. Auroux J, Lamarque D, Roudot-Thoraval F, et al. Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci. 2003;48:1118-1123.